TY - JOUR
T1 - Epigenome-wide study identifies novel methylation loci associated with body mass index and waist circumference
AU - Aslibekyan, Stella
AU - Demerath, Ellen W.
AU - Mendelson, Michael
AU - Zhi, Degui
AU - Guan, Weihua
AU - Liang, Liming
AU - Sha, Jin
AU - Pankow, James S.
AU - Liu, Chunyu
AU - Irvin, Marguerite R.
AU - Fornage, Myriam
AU - Hidalgo, Bertha
AU - Lin, Li An
AU - Stanton Thibeault, Krista
AU - Bressler, Jan
AU - Tsai, Michael Y.
AU - Grove, Megan L.
AU - Hopkins, Paul N.
AU - Boerwinkle, Eric
AU - Borecki, Ingrid B.
AU - Ordovas, Jose M.
AU - Levy, Daniel
AU - Tiwari, Hemant K.
AU - Absher, Devin M.
AU - Arnett, Donna K.
N1 - Publisher Copyright:
© 2015 The Obesity Society.
PY - 2015/7/1
Y1 - 2015/7/1
N2 - Objective To conduct an epigenome-wide analysis of DNA methylation and obesity traits. Methods DNA methylation was quantified in CD4+ T-cells using the Illumina Infinium HumanMethylation450 array in 991 participants of the Genetics of Lipid Lowering Drugs and Diet Network. Methylation at individual cytosine-phosphate-guanine (CpG) sites as a function of body mass index (BMI) and waist circumference (WC), adjusting for age, gender, study site, T-cell purity, smoking, and family structure, was modeled. Results Epigenome-wide significant associations between eight CpG sites and BMI and five CpG sites and WC, successfully replicating the top hits in whole blood samples from the Framingham Heart Study (n-=-2,377) and the Atherosclerosis Risk in Communities study (n-=-2,097), were found. Top findings were in CPT1A (meta-analysis P-=-2.7 × 10-43 for BMI and 9.9 × 10-23 for WC), PHGDH (meta-analysis P-=-2.0 × 10-15 for BMI and 4.0 × 10-9 for WC), CD38 (meta-analysis P-=-6.3 × 10-11 for BMI and 1.6 × 10-12 for WC), and long intergenic non-coding RNA 00263 (meta-analysis P-=-2.2 × 10-16 for BMI and 8.9 × 10-14 for WC), regions with biologically plausible relationships to adiposity. Conclusions This large-scale epigenome-wide study discovered and replicated robust associations between DNA methylation at CpG loci and obesity indices, laying the groundwork for future diagnostic and/or therapeutic applications.
AB - Objective To conduct an epigenome-wide analysis of DNA methylation and obesity traits. Methods DNA methylation was quantified in CD4+ T-cells using the Illumina Infinium HumanMethylation450 array in 991 participants of the Genetics of Lipid Lowering Drugs and Diet Network. Methylation at individual cytosine-phosphate-guanine (CpG) sites as a function of body mass index (BMI) and waist circumference (WC), adjusting for age, gender, study site, T-cell purity, smoking, and family structure, was modeled. Results Epigenome-wide significant associations between eight CpG sites and BMI and five CpG sites and WC, successfully replicating the top hits in whole blood samples from the Framingham Heart Study (n-=-2,377) and the Atherosclerosis Risk in Communities study (n-=-2,097), were found. Top findings were in CPT1A (meta-analysis P-=-2.7 × 10-43 for BMI and 9.9 × 10-23 for WC), PHGDH (meta-analysis P-=-2.0 × 10-15 for BMI and 4.0 × 10-9 for WC), CD38 (meta-analysis P-=-6.3 × 10-11 for BMI and 1.6 × 10-12 for WC), and long intergenic non-coding RNA 00263 (meta-analysis P-=-2.2 × 10-16 for BMI and 8.9 × 10-14 for WC), regions with biologically plausible relationships to adiposity. Conclusions This large-scale epigenome-wide study discovered and replicated robust associations between DNA methylation at CpG loci and obesity indices, laying the groundwork for future diagnostic and/or therapeutic applications.
UR - http://www.scopus.com/inward/record.url?scp=84932615545&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84932615545&partnerID=8YFLogxK
U2 - 10.1002/oby.21111
DO - 10.1002/oby.21111
M3 - Article
C2 - 26110892
AN - SCOPUS:84932615545
SN - 1930-7381
VL - 23
SP - 1493
EP - 1501
JO - Obesity
JF - Obesity
IS - 7
ER -